URMC / Research / Health Research /Clinical Trials / Study Details

PASSAGE: Effectiveness of Tezepelumab, an Injectable Medication, in Treating Severe Asthma

Research Question:
Is tezepelumab, an injectable medication, effective at treating severe asthma in adults and adolescents?

Basic Study Information

Purpose:
Adult and adolescent participants may be eligible if they have severe asthma with 2 or more exacerbations in the last 12 months. The study consists of 15 in-person visits (1 to 3 hours each). Visit 1 will be for eligibility screening. The study drug, tezepelumab, will be given at visits 2-14. Visit 15 will be for follow-up examination.

Study Reference #: STUDY00008180

Lead Researcher (Principal Investigator)

Lead Researcher: Steve Georas

Study Contact Information

Study Coordinator: Marcus Dalfonso
Phone: (585) 276-7296
Email: marcus_dalfonso@urmc.rochester.edu

Additional Study Details

Number of Visits: More than 10
Parking: Reimbursed
Reimbursement: Yes
Payment Details: $60 per visit completed

Contact This Study

First Name *

This field is required

Middle Name

Last Name *

This field is required

Phone Number

I agree to be contacted by The University of Rochester Medical Center regarding participation in this study. *

You must agree to be contacted to continue.

Please call me during the day.

Please call me during the evening.

Message

Return to Search

Research

UR Health Research